CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

(2011) J. Jakubikova et al.   BLOOD

Bone marrow stromal cell interaction reduces Syndecan-1 expression and induces kinomic changes in myeloma cells

(2010) Gwenny M. Fuhler et al.   EXPERIMENTAL CELL RESEARCH

Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma

(2010) S. REID et al.   International Journal of Laboratory Hematology

A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma

(2008) J. Kirshner et al.   BLOOD

Multiple myeloma

(2008) R. A. Kyle et al.   BLOOD

Anti-CD20 monoclonal antibody therapy in multiple myeloma

(2008) Prashant Kapoor et al.   BRITISH JOURNAL OF HAEMATOLOGY

Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

(2008) W. Matsui et al.   CANCER RESEARCH